Gene silencing with CRISPRi in bacteria and optimization of dCas9 expression levels

被引:42
|
作者
Depardieu, Florence [1 ]
Bikard, David [1 ]
机构
[1] Inst Pasteur, Grp Biol Synthese, F-75015 Paris, France
基金
欧洲研究理事会;
关键词
CRISPRi; dCas9; Knockdown; Gene silencing; Staphylococcus aureus; Escherichia coli; RNA; SEQUENCE; INTERFERENCE; PLASMIDS; PROTEIN; FAMILY; CAS9; TRANSFORMATION; MUTAGENESIS; RESISTANCE;
D O I
10.1016/j.ymeth.2019.07.024
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The catalytic null mutant of the Cas9 endonuclease from the bacterial CRISPR immune system, known as dCas9, can be guided by a small RNA to bind DNA sequences of interest and block gene transcription in a strategy known as CRISPRi. This powerful gene silencing method has already been used in a large number of species and in high throughput screens. Here we provide detailed design rules, methods and novel vectors to perform CRISPRi experiments in S. aureus and in E. coli, using the well characterized dCas9 protein from S. pyogenes. In particular, we describe a vector based on plasmid pC194 which is broadly used in Firmicutes, as well as a vector based on the very broad host-range rolling circle plasmid pLZ12, reported to replicate in both Firmicutes and Proteobacteria. A potential caveat of adapting dCas9 tools to various bacterial species is that dCas9 was shown to be toxic when expressed too strongly. We describe a method to optimize the expression level of dCas9 in order to avoid toxicity while ensuring strong on-target repression activity. We demonstrate this method by optimizing a pLZ12 based vector originally developed for S. aureus so that it can work in E. colt. This article should provide all the resources required to perform CRISPRi experiments in a broad range of bacterial species.
引用
收藏
页码:61 / 75
页数:15
相关论文
共 50 条
  • [31] Modularized CRISPR/dCas9 Effector Toolkit for Target-Specific Gene Regulation
    Agne, Michael
    Blank, Ilona
    Emhardt, Alica J.
    Gaebelein, Christoph G.
    Gawlas, Fenja
    Gillich, Nadine
    Gonschorek, Patrick
    Juretschke, Thomas J.
    Kraemer, Stefan D.
    Louis, Natalie
    Mueller, Anne
    Rudorf, Alina
    Schaefer, Lisa M.
    Scheidmann, Manuel C.
    Schmunk, Lisa J.
    Schwenk, Philipp M.
    Stammnitz, Maximilian R.
    Warmer, Philipp M.
    Weber, Wilfried
    Fischer, Adrian
    Kaufmann, Beate
    Wagner, Hanna J.
    Radziwill, Gerald
    ACS SYNTHETIC BIOLOGY, 2014, 3 (12): : 986 - 989
  • [32] Short communication: An inducible CRISPR/dCas9 gene repression system in Lactococcus lactis
    Xiong, Zhi-Qiang
    Wei, Yun-Ying
    Kong, Ling-Hui
    Song, Xin
    Yi, Hua-Xi
    Ai, Lian-Zhong
    JOURNAL OF DAIRY SCIENCE, 2020, 103 (01) : 161 - 165
  • [33] Generation of a dual edited human induced pluripotent stem cell Myl7-GFP line with inducible CRISPRi/dCas9
    Metzl-Raz, Eyal
    Bharucha, Nike
    Ataam, Jennifer Arthur A.
    Gavidia, Alexandra A. J.
    Greenleaf, William J.
    Karakikes, Ioannis
    STEM CELL RESEARCH, 2022, 61
  • [34] CRISPR/dCas9 Activated Expression of Cardiomyocyte Differentiation Factors in CDCs in Myocardial Infarctions
    Sano, T.
    Ishigami, S.
    Bandaru, S.
    Ito, T.
    Sano, S.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3275 - 3275
  • [35] A Neuron-Optimized CRISPR/dCas9 Activation System for Robust and Specific Gene Regulation
    Savell, Katherine
    Bach, Svitlana
    Zipperly, Morgan
    Revanna, Jasmin
    Goska, Nicholas
    Tucher, Jennifer
    Duke, Corey
    Sultan, Faraz
    Burke, Julia
    Ianov, Lara
    Day, Jeremy
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S470 - S470
  • [36] A Neuron-Optimized CRISPR/dCas9 Activation System for Robust and Specific Gene Regulation
    Savell, Katherine E.
    Bach, Svitlana, V
    Zipperly, Morgan E.
    Revanna, Jasmin S.
    Goska, Nicholas A.
    Tuscher, Jennifer J.
    Duke, Corey G.
    Sultan, Faraz A.
    Burke, Julia N.
    Williams, Derek
    Ianov, Lara
    Day, Jeremy J.
    ENEURO, 2019, 6 (01)
  • [37] High-Level dCas9 Expression Induces Abnormal Cell Morphology in Escherichia coli
    Cho, Suhyung
    Choe, Donghui
    Lee, Eunju
    Kim, Sun Chang
    Palsson, Bernhard
    Cho, Byung-Kwan
    ACS SYNTHETIC BIOLOGY, 2018, 7 (04): : 1085 - +
  • [38] Durable HTT Silencing Using Non-Evolved dCas9 Epigenome Editors in Patient-Derived Cells
    Waldo, Jennifer
    Halmai, Julian A. N. M.
    Singh, Ankita
    Florendo, Maria N.
    Nolta, Jan A.
    Fink, Kyle D.
    MOLECULAR THERAPY, 2024, 32 (04) : 777 - 777
  • [39] Comparison and optimization of CRISPR/dCas9/gRNA genome-labeling systems for live cell imaging
    Hong, Yu
    Lu, Guangqing
    Duan, Jinzhi
    Liu, Wenjing
    Zhang, Yu
    GENOME BIOLOGY, 2018, 19
  • [40] The Impact of application of CRISPR /dCas9 systems for increasing the expression of FSH receptor in human granulosa cells
    Guller, A. S.
    Kayabolen, G. N. Sahin
    Soyler, G.
    Comar, M. Y.
    Duzgun, I. Yilmaz
    Sivaslioglu, A.
    Karahuseyinoglu, S.
    HUMAN REPRODUCTION, 2023, 38